Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_001754.5(RUNX1):c.849G>C (p.Gln283His)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA320255629

464011 (ClinVar)

Gene: RUNX1

Condition: hereditary thrombocytopenia and hematologic cancer predisposition syndrome

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 8cd92f32-fdda-4562-844a-b909dc4b1ec3

Approved on: 2024-10-29

Published on: 2024-10-29

HGVS expressions

NM_001754.5:c.849G>C

NM_001754.5(RUNX1):c.849G>C (p.Gln283His)

NC_000021.9:g.34799419C>G

CM000683.2:g.34799419C>G

NC_000021.8:g.36171716C>G

CM000683.1:g.36171716C>G

NC_000021.7:g.35093586C>G

NG_011402.2:g.1190293G>C

ENST00000675419.1:c.849G>C

ENST00000300305.7:c.849G>C

ENST00000344691.8:c.768G>C

ENST00000399240.5:c.576G>C

ENST00000437180.5:c.849G>C

ENST00000482318.5:c.*439G>C

NM_001001890.2:c.768G>C

NM_001754.4:c.849G>C

NM_001001890.3:c.768G>C

Uncertain Significance

PS4_Supporting

BS2 BS4 BS3 BS1 PVS1 BP2 BP3 BP4 BP1 BP5 BP7 PS2 PS1 PS3 BA1 PP4 PP1 PP3 PP2 PM6 PM2 PM5 PM3 PM1 PM4

Evidence Links 0

Expert Panel

Myeloid Malignancy VCEP

Criteria Specification Information

Criteria Specification: ClinGen Myeloid Malignancy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Myeloid Malignancy VCEP

NM_001754.5(RUNX1):c.849G>C (p.Gln283His) is a missense variant which has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_ Supporting; PMID: 36819173). In summary, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PS4_supporting.

PS4_Supporting

This variant has been reported in one proband meeting at least one of the RUNX1-phenotypic criteria (PS4_ Supporting; PMID: 36819173).

BS2

This rule is not applicable for MM-VCEP

BS4

Segregation data for this variant has not been reported in literature.

BS3

In vitro or in vivo data has not been reported for this variant in the literature.

BS1

This variant does not have a MAF between 0.00015 (0.015%) and 0.0015 (0.15%) in any general continental dataset.

PVS1

This variant is not a null variant.

BP2

This variant has not been observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder or observed in cis with a pathogenic variant in any inheritance pattern.

BP3

This rule is not applicable for MM-VCEP

BP4

This missense variant does not have a REVEL score < 0.50.

BP1

This rule is not applicable for MM-VCEP

BP5

This rule is not applicable for MM-VCEP

BP7

This variant is not a synonymous or intronic variant.

PS2

This variant does not have a confirmed de novo case reported in the literature.

PS1

There has not yet been a missense change determined to be pathogenic at this amino acid residue.

PS3

In vitro or in vivo data has not been reported for this variant in the literature.

BA1

This variant does not have a MAF ≥ 0.0015 (0.15%) in any general continental population dataset.

PP4

This rule is not applicable for MM-VCEP

PP1

Segregation data for this variant has not been reported in literature.

PP3

This missense variant does not have a REVEL score of ≥ 0.88.

PP2

This rule is not applicable for MM-VCEP

PM6

This variant does not have two or more assumed de novo occurrences in the literature.

PM2

This variant is present in at least one population dataset.

PM5

There has not yet been a different missense change determined to be pathogenic at this amino acid residue.

PM3

This rule is not applicable for MM-VCEP

PM1

This variant does not affect any of the following amino acid residues, nor is it located within the RHD: R107, K110, A134, R162, R166, S167, R169, G170, K194, T196, D198, R201, R204 OR within residues 89-204.

PM4

This variant is not an in-frame deletion/insertion.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.